Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record for the completed cabozantinib study in recurrent or metastatic endometrial cancer is displayed, including study details and results-related information. A protocol and statistical analysis plan document is also listed.
    Difference
    67%
    Check dated 2026-11-11T00:49:10.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page, with the footer revision identifier changing from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:17:23.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence.” The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:49:46.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:23:23.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the expected content. This makes the record inaccessible and prevents viewing the trial details.
    Difference
    20%
    Check dated 2026-09-22T23:54:15.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page shows Revision: v3.7.0 instead of v3.6.6, indicating a software update to the Study Details page. There are no observed changes to the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-15T23:55:18.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.